News
PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Tuesday reported a loss of $59.9 million in its first quarter. The Pleasanton, California-based company said it ...
We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other genomics ...
Kevin Wei, M.D., Ph.D., ... About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health.
10x Genomics slashed its FY24 revenue guidance from $640 million-$5660 million to $595 million-$605 million. 10x Genomics shares gained 6.3% to trade at $16.79 on Wednesday.
10x Genomics: Q1 Earnings Snapshot May 8, 2025 PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter.
In trading on Monday, shares of 10x Genomics Inc (Symbol: TXG) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $11.8955 per share.
10x Genomics (NASDAQ: TXG), a biotechnology company that designs and manufactures gene sequencing technology, was listed following its IPO in September. While the stock saw some volatility post ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results